AZD4063
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD4063, covering 2026-03-31 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study of AZD4063 in PLN R14del Dilated Cardiomyopathy [Phase 1]